Novo Nordisk cuts 2025 sales and profit forecast amid obesity drug challenges
Novo Nordisk has lowered its full-year 2025 sales and operating profit forecasts due to weaker-than-expected growth in its key obesity and diabetes drugs, the Danish drugmaker announced Tuesday. Novo Nordisk employs more than 400 people at its West Lebanon, NH, location.